MRNS logo

Marinus Pharmaceuticals (MRNS) Return On Equity

Annual ROE

-213.02%
-189.64%-811.12%

December 31, 2023


Summary


Performance

MRNS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNSprofitabilitymetrics:

Quarterly ROE

494.02%
+1644.45%+142.94%

September 30, 2024


Summary


Performance

MRNS Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNSprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

MRNS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-811.1%0.0%
3 y3 years-255.1%+1579.5%
5 y5 years-266.4%+1579.5%

MRNS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-811.1%at lowat high+142.9%
5 y5-year-811.1%at lowat high+142.9%
alltimeall time-811.1%at lowat high+142.9%

Marinus Pharmaceuticals ROE History

DateAnnualQuarterly
Sep 2024
-
494.02%(-142.9%)
Jun 2024
-
-1150.43%(+212.3%)
Mar 2024
-
-368.35%(+71.8%)
Dec 2023
-213.02%(+811.1%)
-214.43%(+26.5%)
Sep 2023
-
-169.57%(+322.9%)
Jun 2023
-
-40.10%(-25.2%)
Mar 2023
-
-53.59%(+60.5%)
Dec 2022
-23.38%(-77.4%)
-33.39%(+25.3%)
Sep 2022
-
-26.64%(-86.4%)
Jun 2022
-
-195.79%(+64.7%)
Mar 2022
-
-118.86%(+15.4%)
Dec 2021
-103.60%(+72.7%)
-102.98%(+20.3%)
Sep 2021
-
-85.63%(+9.2%)
Jun 2021
-
-78.42%(+13.9%)
Mar 2021
-
-68.87%(+1.3%)
Dec 2020
-59.99%(-13.5%)
-67.97%(-9.7%)
Sep 2020
-
-75.27%(-12.9%)
Jun 2020
-
-86.39%(-14.2%)
Mar 2020
-
-100.63%(+5.1%)
Dec 2019
-69.34%
-95.72%(+1.3%)
Sep 2019
-
-94.47%(+6.4%)
Jun 2019
-
-88.80%(+6.0%)
DateAnnualQuarterly
Mar 2019
-
-83.81%(+15.0%)
Dec 2018
-58.14%(+22.3%)
-72.87%(+11.2%)
Sep 2018
-
-65.56%(+46.5%)
Jun 2018
-
-44.74%(+8.9%)
Mar 2018
-
-41.07%(-15.4%)
Dec 2017
-47.55%(-43.2%)
-48.57%(-28.3%)
Sep 2017
-
-67.75%(-36.9%)
Jun 2017
-
-107.37%(-0.3%)
Mar 2017
-
-107.73%(+13.8%)
Dec 2016
-83.75%(+48.4%)
-94.64%(+14.6%)
Sep 2016
-
-82.57%(+4.5%)
Jun 2016
-
-79.03%(+12.7%)
Mar 2016
-
-70.10%(-3.3%)
Dec 2015
-56.43%(+31.8%)
-72.47%(+14.2%)
Sep 2015
-
-63.46%(+35.5%)
Jun 2015
-
-46.82%(-6.5%)
Mar 2015
-
-50.10%(+13.8%)
Dec 2014
-42.81%(-44.6%)
-44.04%(-14.8%)
Sep 2014
-
-51.69%(-52.6%)
Jun 2014
-
-109.15%(+50.3%)
Mar 2014
-
-72.63%(+30.3%)
Dec 2013
-77.27%(+129.4%)
-55.72%
Dec 2012
-33.68%
-

FAQ

  • What is Marinus Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Marinus Pharmaceuticals?
  • What is Marinus Pharmaceuticals annual ROE year-on-year change?
  • What is Marinus Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Marinus Pharmaceuticals?
  • What is Marinus Pharmaceuticals quarterly ROE year-on-year change?

What is Marinus Pharmaceuticals annual return on equity?

The current annual ROE of MRNS is -213.02%

What is the all time high annual ROE for Marinus Pharmaceuticals?

Marinus Pharmaceuticals all-time high annual return on equity is -23.38%

What is Marinus Pharmaceuticals annual ROE year-on-year change?

Over the past year, MRNS annual return on equity has changed by -189.64% (-811.12%)

What is Marinus Pharmaceuticals quarterly return on equity?

The current quarterly ROE of MRNS is 494.02%

What is the all time high quarterly ROE for Marinus Pharmaceuticals?

Marinus Pharmaceuticals all-time high quarterly return on equity is 494.02%

What is Marinus Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, MRNS quarterly return on equity has changed by 0.00% (0.00%)